Day One Biopharmaceuticals ( NASDAQ:DAWN – Get Rating ) announced its earnings results on Monday. The company reported ($0.59) EPS for the quarter, meeting analysts' consensus estimates of ($0.59), MarketWatch Earnings reports. Day One Biopharmaceuticals Trading Down 0.9 % DAWN stock traded down $0.12 during midday trading on Wednesday, hitting $13.86. 90,995 shares of the company's stock were exchanged, compared to its average volume of 744,234. The business has a 50-day simple moving average of $15.

https://www.dailypolitical.com/2023/05/03/day-one-biopharmaceuticals-nasdaqdawn-posts-earnings-results.html

#dailypolitical